Description

Buy Pharmacom Labs Hennos 10 Oral Steroid 50 tabs

Hennos Oral 10mg Tablets (GW1516) – 50 Tablets Blister Pack

Product Description

Hennos Oral 10mg Tablets are presented in a pharmaceutical-grade blister pack containing 50 tablets, each delivering a precisely measured 10mg dose of the active compound GW1516 (also known as Cardarine, GW501516, and Endurobol). GW1516 is a peroxisome proliferator-activated receptor delta (PPARδ) agonist originally developed through a research collaboration between Ligand Pharmaceuticals and GlaxoSmithKline in the 1990s for the investigation of metabolic and cardiovascular conditions.

As a metabolic modulator, GW1516 functions by activating the PPARδ receptor, which regulates muscle metabolism and has been shown to reprogram muscle fibre types. This mechanism influences fatty acid oxidation and energy expenditure at the cellular level. The compound has been the subject of Phase II and IV clinical trials investigating its effects on dyslipidemia and lipoprotein transport in metabolic syndrome conditions.

The blister packaging provides optimal protection for each tablet, maintaining product integrity and stability while enabling convenient storage and precise dosage administration. Each tablet contains a uniform 10mg concentration, allowing for accurate and consistent dosing.

Key Information

• Active Component: GW1516 (GW501516, Cardarine)

• Dosage: 10mg per tablet

• Quantity: 50 tablets per blister pack

• Classification: PPARδ agonist / Metabolic modulator

Frequently Asked Questions

1. What is GW1516 and how does it work?

GW1516, also known as Cardarine or Endurobol, is a synthetic compound that acts as a selective agonist of the PPARδ receptor. It functions as a metabolic modulator that increases fat metabolism and improves exercise adaptation. The compound is classified as an exercise mimetic, meaning it mimics certain physiological effects of exercise, including increased fat burning and promotion of Type I (slow-twitch) muscle fibre production. It is important to note that GW1516 is not a SARM (selective androgen receptor modulator) but belongs to the class of PPAR agonists.

2. What is the recommended dosage of Hennos Oral 10mg tablets?

The standard dosage used by many individuals is 10mg per day, which is considered a performance-level dose. Some protocols utilise doses ranging from 5mg (minimal dose for endurance improvements and lipid support) up to 20mg (higher-end dose often used in aggressive cycles). A healthcare professional should be consulted to determine appropriate dosing for individual health needs.

3. What are the purported benefits of GW1516?

Purported benefits associated with GW1516 include weight loss and fat loss, improved metabolic function, support for diabetes management, enhanced blood lipid profiles, and improved sports performance. However, it is critical to recognise that the majority of studies on this compound have been conducted in animals, and human data remains extremely limited. There is no good scientific evidence to support its use in humans.

4. Is GW1516 approved for human use?

GW1516 is not approved for therapeutic use in any country. It is not listed on any national register of therapeutic goods and is not legally permitted in medications, supplements, or foods. The compound is sometimes marketed as a research chemical with labelling stating not for human use or for laboratory use only.

5. What is the legal status of GW1516?

GW1516 is prohibited at all times under the World Anti-Doping Agency (WADA) Prohibited List, classified under S4.4.1 Metabolic Modulators. It was added to the WADA Prohibited List in 2009 under section S.4 Hormone and Metabolic Modulators. The Australian Therapeutic Goods Administration (TGA) lists GW1516 under Schedule 10 – Substances of such danger to health as to warrant prohibition of sale, supply and use.

6. What are the known health risks and side effects of GW1516?

GW1516 is associated with significant health risks. Clinical trials were abandoned after research linked the compound to cancer development in animals. Studies revealed that the drug caused cancer to develop rapidly in various organs. Documented adverse effects include high frequency of carcinogenicity and reproductive toxicity. Reported side effects in users have included stomach pain, muscle pain, and severe headaches. The compound has not undergone adequate human studies and is considered unsafe for human use.

7. Can GW1516 be detected in drug tests?

Yes, GW1516 and its metabolites are detectable in urine using LC-MS/MS based procedures. The sulfone metabolites of GW1516 have been shown to be detectable in urine for up to 40 days after a single oral dose of 15mg. Multiple athletes have tested positive for the substance and faced sanctions.

8. Can a Therapeutic Use Exemption (TUE) be obtained for GW1516?

No. A Therapeutic Use Exemption would not be granted for the use of GW1516 as it is not available anywhere as an approved medication and has no recognised therapeutic uses.

9. Is Hennos Oral the same as other GW1516 products?

Hennos is a synonym for GW1516, also known as Cardarine, Endurobol, Peroximod, and GW-501516. Hennos Oral 10mg tablets contain the same active compound GW1516 found in other products marketed under various brand names.

10. What precautions should be taken before using this product?

Given that GW1516 has been associated with significant health risks including carcinogenicity, has not been approved for human therapeutic use, and is prohibited in sport, individuals should exercise extreme caution. Consulting with a qualified healthcare professional is essential before considering any use of this compound. The substance is banned by WADA and its sale and use is prohibited in many jurisdictions.

---

References and Reputable Sources

• World Anti-Doping Agency (WADA): GW1516 is listed on the Prohibited List under S4.4.1 Metabolic Modulators

• USADA (U.S. Anti-Doping Agency): Provides comprehensive information on GW1516, including health risks and legal status

• Sport Integrity Australia: Detailed substance education on GW1516, including TGA scheduling and health warnings

• Healthline: Overview of Cardarine, including purported benefits, side effects, and current availability

• WebMD: Fast facts on Cardarine covering uses, side effects, and safety information

• PubMed / PMC: Peer-reviewed research on PPARδ agonists and their mechanisms of action

---

Explore Hennos Oral 10mg Tablets – 50 Tablets Blister Pack and other premium products at AnabolicSteroidsOnline.shop. Visit the site today to review the full product range and place your